This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Clorox (CLX) Stock is Up 3% Post Q3 Earnings
by Zacks Equity Research
Clorox (CLX) is gaining from a robust surprise trend as well progress on its 2020 Strategy and e-commerce initiatives. However, the company's soft margins are keeping us on the sidelines.
Brown-Forman Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Brown-Forman (BF.B) touches a 52-week high on the back of its robust strategies, including growth and expansion plans, solid brand portfolio along with an impressive surprise trend.
AB InBev (BUD) Q1 Earnings Lag, Global Brands Aid Sales Beat
by Zacks Equity Research
AB InBev (BUD) reports lower-than-expected earnings per share in first-quarter 2018 while sales beat estimates. Sales gain from strong global brands and revenue management initiatives.
Avon Products (AVP) Q1 Loss Meets Estimates, Revenues Top
by Zacks Equity Research
Avon (AVP) reports first-quarter 2018 loss per share in line with estimates while sales beat. Active Representatives remain a key hurdle for growth.
Solid Volumes Fuel Church & Dwight (CHD) Q1 Earnings & Sales
by Zacks Equity Research
Church & Dwight (CHD) posts solid Q1 results. Both earnings and sales rise year over year and beat expectations.
Zacks.com highlights: Rocky Brands, Boston Beer, Conagra Brands, DMC Global and United States Cellular
by Zacks Equity Research
Zacks.com highlights: Rocky Brands, Boston Beer, Conagra Brands, DMC Global and United States Cellular
Low Volumes Hit Molson Coors (TAP) in Q1 Earnings, Stock Down
by Zacks Equity Research
Molson Coors (TAP) top and bottom lines dropped year over year and missed the Zacks Consensus Estimate in Q1.
Buy 5 Low-Beta Stocks for Immunity to Market Volatility
by Zacks Equity Research
In this article we present a strategy which clearly shows less risky securities could also reward investors with impressive returns.
Stock Market News For Apr 26, 2018
by Zacks Equity Research
The Dow and S&P 500 bounced back on Wednesday, ending its five-day losing streak on robust corporate earnings that somewhat eclipsed fears of rising U.S. bond yields
Boston Beer (SAM) Q1 Earnings & Sales Beat, 2018 View Intact
by Zacks Equity Research
Boston Beer's (SAM) earnings and sales top estimates in first-quarter 2018, backed by improved shipments and depletions as well as higher gross margin. The company reiterates earnings view for 2018.
Will Cost-Saving Plans Boost PepsiCo's (PEP) Q1 Earnings?
by Zacks Equity Research
PepsiCo's (PEP) Q1 results are likely to benefit from higher cost-saving plans. However, tepid revenue growth, higher inflation, and increase in advertising and marketing expenses might pose risks.
Will FEMSA (FMX) Repeat its Dismal Earnings Trend in Q1?
by Zacks Equity Research
FEMSA (FMX) gains on strategic actions like store expansion, portfolio diversification and focus on core business. However, near-term headwinds like dismal surprise trend and soft margins are concerns.
Is Colgate (CL) Poised for Another Earnings Surprise in Q1?
by Zacks Equity Research
Colgate-Palmolive (CL) remains confident of the brand building and productivity maximization initiatives, which are likely to boost results in 2018. However, strained margins may pose concerns.
Can Solid Sales Endeavors Fuel Nu Skin (NUS) Q1 Earnings?
by Zacks Equity Research
We expect Nu Skin (NUS) to continue gaining from its efforts to strengthen customer base and drive sales. This includes social media activities to help sales leaders and solid product strategies.
Will Cost Cut, Innovations Drive Coca-Cola (KO) Q1 Earnings?
by Zacks Equity Research
Softness in revenues due to weak soda volumes and structural changes might affect Coca-Cola's (KO) Q1 results. However, focus on reducing costs might boost margins.
Columbia Sportswear (COLM) Q1 Earnings to Grow Y/Y: Here's Why
by Zacks Equity Research
We expect Columbia Sportswear (COLM) to continue gaining from its brand enhancing initiatives as well as solid geographic reach.
Will Product Launches Aid Boston Beer's (SAM) Q1 Earnings?
by Zacks Equity Research
Boston Beer (SAM) has been struggling with soft depletion trends and shipment volumes. Though it issued encouraging shipments and depletions outlook for 2018, management expects volumes to remain sensitive.
Will SUPERVALU's (SVU) Wholesale Business Drive Q4 Earnings?
by Zacks Equity Research
SUPERVALU (SVU) is likely to maintain sturdy wholesale business performance in Q4. However, the retail unit remains a drag.
2 Booze Stocks Mirror Industry Strength, Hit 52-Week High
by Zacks Equity Research
Boston Beer (SAM) and Constellation Brands (STZ) hit 52-week high yesterday on their robust strategic endeavors and favorable market trends.
Cost-Cutting Plans to Fuel Kimberly-Clark (KMB) Q1 Earnings
by Zacks Equity Research
We remain encouraged about Kimberly-Clark's (KMB) upcoming performance, given its solid FORCE program and recently announced 2018 Global Restructuring plan.
The Boston Beer Company (SAM) Down 4.2% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
The Boston Beer Company (SAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Boston Beer (SAM) Rallies Despite a Dismal Q4
by Zacks Equity Research
While Boston Beer (SAM) fails to impress investors in the fourth quarter, its cost-saving plans and long-term innovation alongside the focus on reviving its brands keep the stock ticking.
Boston Beer (SAM) Misses Q4 Earnings Estimates, Updates View
by Zacks Equity Research
Boston Beer (SAM) posted lower-than-expected results for the fourth quarter of 2017. However, the company remains committed toward a three-point growth plan.
Forget Walmart's Miss, Buy These Stocks Likely to Beat Earnings
by Ryan McQueeney
Stocks opened lowered on Tuesday after Walmart's earnings report disappointed investors. Here's a look at three other stocks that are expected to beat earnings estimates this week.
Can Clorox's (CLX) Strategic Efforts Help It Regain Momentum?
by Zacks Equity Research
Clorox's (CLX) 2020 Strategy aimed at boosting growth for the improvement of categories and overall market share bodes well.